Learn About Cabenuva Injections and HIV Treatment Options

Cabenuva is a long acting injectable HIV treatment option for certain adults and adolescents living with HIV. It combines cabotegravir and rilpivirine and is administered by a healthcare professional rather than taken as a daily oral tablet. Understanding how Cabenuva works, who may be eligible, the injection schedule, possible side effects, and the importance of maintaining treatment appointments can help people make informed decisions with their healthcare providers. Other HIV treatment options remain available, including daily oral antiretroviral therapy.

Cabenuva is a long acting injectable regimen used to treat HIV in people who meet specific eligibility requirements. It contains two antiretroviral medicines, cabotegravir and rilpivirine, which work at different stages of the HIV life cycle. Unlike daily oral treatment, Cabenuva is administered as injections by a healthcare professional according to an established schedule. Treatment decisions should be made with a qualified healthcare provider after considering a person's HIV treatment history, viral suppression, medications, and other health factors.

How Cabenuva Injections Work

Cabenuva contains cabotegravir, an integrase strand transfer inhibitor, and rilpivirine, a nonnucleoside reverse transcriptase inhibitor. Together, these medicines interfere with HIV replication. The regimen is intended for people whose HIV is already controlled under specific treatment conditions.

Before starting Cabenuva, healthcare professionals generally review whether the person is an appropriate candidate and consider factors such as previous HIV medications, resistance history, and current viral load. The injections are given into the muscles of the buttocks by a healthcare professional.

Important considerations include:

• Cabenuva is a prescription HIV treatment and should be used under medical supervision.
• The injection schedule should be followed carefully to maintain appropriate medication levels.
• Some people may receive oral medicines before beginning injections to assess tolerability, depending on their treatment plan.
• Injection-site reactions, such as pain, swelling, or tenderness, can occur.
• Missing scheduled injections may require additional medical guidance and temporary oral treatment.

Other HIV Treatment Options

Cabenuva is one option within modern antiretroviral therapy. Daily oral HIV medicines remain widely used and may be appropriate for many people. The choice of treatment depends on individual circumstances, including other medications, resistance patterns, lifestyle considerations, possible side effects, and healthcare access.

Other treatment considerations can include:

• Daily single-tablet or combination antiretroviral regimens.
• Different classes of antiretroviral medicines used in combination.
• Medication adjustments when resistance or side effects occur.
• Regular monitoring of viral load and other health indicators.
• Discussions about adherence, drug interactions, and long-term treatment goals.

Effective HIV treatment can suppress the virus to very low levels and help people maintain their health. Consistent treatment is important because interruptions can allow HIV to increase and may contribute to drug resistance in some circumstances.

Cabenuva provides a long acting injectable approach to HIV treatment for people who meet its eligibility requirements. Understanding the injection schedule, potential reactions, treatment requirements, and available alternatives can help individuals have informed discussions with their healthcare providers. Cabenuva is not appropriate for everyone, so treatment selection should be based on individualized medical assessment.